-
FDA setting stage for NDUFA with June public meeting
SILVER SPRING, Md. - OTC suppliers may soon have a streamlined highway to the kind of sales-driving product innovation that Rx-to-OTC switch generates using monographs, according to an announcement from the Food and Drug Administration issued Tuesday. However, it may be a toll road.Niche pain relief products see significant growth
Niche products like external analgesics, both creams and patches, continue to represent significant incremental value to the overall pain-relieving category. According to the latest IRI figures, sales of external analgesics were up 8.6% to $560.2 million for the 52 weeks ended March 20 across total U.S. multi-outlets.